Mycobacterium xenopi pulmonary disease - Epidemiology and clinical features in non-immunocompromised patients

Journal of Infection

Volumn 58, Issue 2, 2009, Pages 108-112

  Marušić, Ante ^a   Katalinić Janković, Vera ^b   Popović Grle, Sanja ^a   Janković, Mateja ^a   Mažuranić, Ivica ^a   Puljić, Igor ^a   Sertić Milić, Helga ^a  

^a University Hospital for Lung Diseases Jordanovac   (Croatia)

^b Croatian National Mycobacteria Reference Laboratory   (Croatia)

Author keywords

Chronic obstructive pulmonary disease (COPD); Mycobacteriosis; Mycobacterium xenopi; Non tuberculous mycobacteria

Indexed keywords

ANTIMYCOBACTERIAL AGENT; CLARITHROMYCIN; ETHAMBUTOL; ISONIAZID; RIFAMPICIN;

ADULT; AGED; ARTICLE; BACTERIUM DETECTION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; COMORBIDITY; CROATIA; DISEASE PREDISPOSITION; FEMALE; HUMAN; IMMUNOCOMPETENCE; LUNG INFECTION; MALE; MYCOBACTERIOSIS; MYCOBACTERIUM XENOPEI; PROGNOSIS; RETROSPECTIVE STUDY; THORAX RADIOGRAPHY; TREATMENT RESPONSE; TUBERCULOSIS;

AGE FACTORS; AGED; AGED, 80 AND OVER; COMORBIDITY; CROATIA; FEMALE; HUMANS; LUNG DISEASES; MALE; MIDDLE AGED; MYCOBACTERIUM INFECTIONS, ATYPICAL; MYCOBACTERIUM XENOPI; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RADIOGRAPHY, THORACIC; RETROSPECTIVE STUDIES;

EID: 59749101803     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2009.01.001     Document Type: Article

References (30)

1. Tortoli E. The new mycobacteria: an update. FEMS Immunol Med Microbiol 48 (2006) 159-178
2. Schwabacher H. A strain of Mycobacterium isolated from skin lesions of a cold-blooded animal, Xenopus laevis, and its relation to atypical acid-fast bacilli occurring in man. J Hyg (Lond) 57 (1959) 57-67
3. Sniadack D.H., Ostroff S.M., Karlix M.A., Smithwick R.W., Schwartz B., Sprauer M.A., et al. A nosocomial pseudo-outbreak of Mycobacterium xenopi due to contaminated potable water supply: lessons in prevention. Infect Control Hosp Epidemiol 14 (1993) 636-641
4. Dailloux M., Abalain M.L., Laurain C., Lebrun L., Loos-Ayav C., Lozniewski A., et al. French Mycobacteria Study Group. Respiratory infections associated with nontuberculous mycobacteria in non-HIV patients. Eur Respir J 28 (2006) 1211-1215
5. Yates M.D., Grange J.M., and Colins C.H. The nature of mycobacterial disease in southeast England, 1974-84. J Epidemiol Community Health 40 (1986) 295-300
6. Bodle E.E., Cunningham J.A., Della-Latta P., Schluger N.W., and Saiman L. Epidemiology of nontuberculous mycobacteria in patients without HIV infection, New York City. Emerg Infect Dis 14 (2008) 390-396
7. van Ingen J., Boeree M.J., de Lange W.C., Hoefsloot W., Bendien S.A., Magis-Escurra C., et al. Mycobacterium xenopi clinical relevance and determinants, The Netherlands. Emerg Infect Dis 14 (2008) 385-389
8. Thomsen V.O., Andersen A.B., and Miörner H. Incidence and clinical significance of non-tuberculous mycobacteria isolated from clinical specimens during a 2-y nationwide survey. Scand J Infect Dis 34 (2002) 648-653
9. American Thoracic Society. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am J Respir Crit Care Med 156 (1997) S1-S25
10. Griffith D.E., Aksamit T., Brown-Elliott B.A., Catanzaro A., Daley C., Gordin F., et al., ATS Mycobacterial Diseases Subcommittee, American Thoracic Society, Infectious Disease Society of America. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175 4 (2007 August 15) 367-416 [Erratum in: Am J Respir Crit Care Med 2007,1;175(7):744-5]
11. British Thoracic Society. Management of opportunist mycobacterial infections: Joint Tuberculosis Committee guidelines 1999. Thorax 55 (2000) 210-218
12. Tsukamura M. Identification of mycobacteria (1975), The National Sanatorium Chubu Chest Hospital, Obu, Aichi-ken, Japan
13. Public Health Mycobacteriology. A guide for the level III laboratory (1985), US Department of Health and Human Services, Atlanta, Georgia
14. Leao S.C., Martin A., Mejia G.I., Palomino J.C., Robledo J., Telles M.A.S., et al. Practical handbook for the phenotypic and genotypic identification of mycobacteria (2004), Vanden Broele, Brugges, Belgium
15. Donnabella V., Salazar-Schicchi J., Bonk S., Hanna B., and Rom W.N. Increasing incidence of Mycobacterium xenopi at Bellevue Hospital: an emerging pathogen or a product of improved laboratory methods?. Chest 118 (2000) 1365-1370
16. Johnson M.M., Waller E.A., and Leventhal J.P. Nontuberculous mycobacterial pulmonary disease. Curr Opin Pulm Med 14 3 (2008) 203-210
17. Katalinić-Janković V., Popović Grle S., Obrovac M., Cvetnić Z., and Alfirević T. Infekcije izazvane netuberkuloznim mikobakterijama. Liječ Vjesn 129 (2007) 146-151
18. Croatian health service yearbook 2006 (2007), Croatian National Institute of Public Health, Zagreb, Croatia p. 207-9
19. Jarzembowski J.A., and Young M.B. Nontuberculous mycobacterial infections. Arch Pathol Lab Med 132 8 (2008) 1333-1341
20. Jenkins P.A., Campbell I.A., and Research Committee of The British Thoracic Society. Pulmonary disease caused by Mycobacterium xenopi in HIV-negative patients: five year follow-up of patients receiving standardised treatment. Respir Med 97 (2003) 439-444
21. Marras T.K., and Daley C.L. Epidemiology of human pulmonary infection with nontuberculous mycobacteria. Clin Chest Med 2 (2002) 553-567
22. Holland S.M. Nontuberculous mycobacteria. Am J Med Sci 321 (2001) 49-55
23. Contreras M.A., Cheung O.T., Sanders D.E., and Goldstein R.S. Pulmonary infection with non-tuberculous mycobacteria. Am Rev Respir Dis 137 (1988) 149-152
24. Erasmus J.J., McAdams H.P., Farrell M.A., and Patz Jr E.F. Pulmonary nontuberculous mycobacterial infection: radiologic manifestations. Radiographics 19 (1999) 1487-1503
25. Woodring J.H., and Vandiviere H.M. Pulmonary disease caused by nontuberculous mycobacteria. J Thorac Imaging 5 (1990) 64-76
26. Henry M.T., Inamdar L., O'Riordain D., Schweiger M., and Watson J.P. Nontuberculous mycobacteria in non-HIV patients: epidemiology, treatment and response. Eur Respir J 23 (2004) 741-746
27. Manfredi R., Nanetti A., Morelli S., Ferri M., Valentini R., Calza L., et al. A decade surveillance study of Mycobacterium xenopi disease and antimicrobial susceptibility levels in a reference teaching hospital of northern Italy: HIV-associated versus non-HIV-associated infection. HIV Clin Trials 5 (2004) 206-215
28. Glassroth J. Pulmonary disease due to nontuberculous mycobacteria. Chest 133 (2008) 243-251
29. Sexton P., and Harrison A.C. Susceptibility to nontuberculous mycobacterial lung disease. Eur Respir J 31 (2008) 1322-1333
30. Lam P.K., Griffith D.E., Aksamit T.R., Ruoss S.J., Garay S.M., Daley C.L., et al. Factors related to response to intermittent treatment of Mycobacterium avium complex lung disease. Am J Respir Crit Care Med 173 11 (2006) 1283-1289